We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Enovis Corporation (ENOV) USD0.001

Sell:$45.00 Buy:$88.43 Change: $0.97 (1.72%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:$45.00
Buy:$88.43
Change: $0.97 (1.72%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:$45.00
Buy:$88.43
Change: $0.97 (1.72%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.

Contact details

Address:
2711 CENTERVILLE ROAD, SUITE 400
WILMINGTON
19808
United States
Telephone:
+1 (302) 2529160
Website:
https://www.enovis.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ENOV
ISIN:
US1940145022
Market cap:
$3.08 billion
Shares in issue:
54.84 million
Sector:
Health Care Equipment
Exchange:
-
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Matthew Trerotola
    Chairman of the Board, Chief Executive Officer
  • Phillip Berry
    Chief Financial Officer, Executive Vice President
  • Terry Ross
    Group President - Prevention and Recovery
  • Louie Vogt
    Group President - Reconstructive
  • Patricia Lang
    Chief Human Resource Officer, Senior Vice President
  • Daniel Pryor
    Executive Vice President - Strategy and Business Development
  • Bradley Tandy
    Senior Vice President, General Counsel, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.